Frank OSchell New VP of US Sales at PROTEOR USA

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

Frank Oschell has been appointed to Vice President of U.S. Sales, effective immediately. PROTEOR USA annonced the news today.

Frank Oschel joins the PROTEOR USA team, boasting 24 years of experience in the medical field, half of that time spent at Ottobock Healthcare. With expertise in the development and training of consultative, solutions-based sales teams, and in cooperation with value-added marketing and clinically driven education, Frank has gained recognition as a top-performing, results-driven, business leader.

PROTEOR USA President and CEO Matt Swiggum shares: “I am excited to continue building our incredible team at PROTEOR with the addition of Frank Oschell to lead our U.S. Sales and Development activities. He is a seasoned sales professional with strong sales and organizational abilities that I had the pleasure of experiencing first-hand during our time together at Ottobock. As the leader of its fastest-growing business unit, his growth has been founded in his focus on supporting the success of his customers.”

Steve Sherman, previously Vice President of U.S. Sales, passes the torch to Frank Oschell while moving to focus on the development of new global distribution channels while reinforcing current partnerships in an ever-growing international marketplace. Swiggum continues: “With Frank’s focus on the U.S., we are able to focus pivotal resources on international activities. Steve Sherman has accepted the dedicated position as Vice President of International Sales. He has been very instrumental in building the RUSH business and has an entrepreneurial drive that will enable us to continue our rapid growth on a global level.”

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.